vs
Side-by-side financial comparison of ACADIA REALTY TRUST (AKR) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
ACADIA REALTY TRUST is the larger business by last-quarter revenue ($103.0M vs $70.6M, roughly 1.5× Viridian Therapeutics, Inc.\DE). ACADIA REALTY TRUST runs the higher net margin — 135.1% vs -49.0%, a 184.1% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -1.3%).
Acadia Realty Trust is a publicly traded real estate investment trust (REIT) that specializes in owning, operating, and redeveloping high-quality retail and mixed-use properties, primarily in dense, high-barrier-to-entry U.S. markets. Its portfolio includes neighborhood shopping centers, urban street retail assets, and community-focused mixed-use developments.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
AKR vs VRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $103.0M | $70.6M |
| Net Profit | $139.1M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 153.9% | -56.7% |
| Net Margin | 135.1% | -49.0% |
| Revenue YoY | -1.3% | 81958.1% |
| Net Profit YoY | -58.2% | 54.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $103.0M | — | ||
| Q3 25 | — | $70.6M | ||
| Q4 24 | $93.3M | — | ||
| Q3 24 | $87.7M | — | ||
| Q2 24 | $87.3M | — | ||
| Q1 24 | $91.4M | — | ||
| Q4 23 | $85.5M | — | ||
| Q3 23 | $81.4M | — |
| Q1 26 | $139.1M | — | ||
| Q3 25 | — | $-34.6M | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $12.3M | — | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $-6.9M | — | ||
| Q4 23 | $-10.2M | — | ||
| Q3 23 | $-16.3M | — |
| Q1 26 | 153.9% | — | ||
| Q3 25 | — | -56.7% | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 20.4% | — | ||
| Q1 24 | 15.3% | — | ||
| Q4 23 | 12.4% | — | ||
| Q3 23 | 8.2% | — |
| Q1 26 | 135.1% | — | ||
| Q3 25 | — | -49.0% | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 14.0% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | -7.5% | — | ||
| Q4 23 | -12.0% | — | ||
| Q3 23 | -20.0% | — |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.07 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $0.03 | — | ||
| Q4 23 | $-0.01 | — | ||
| Q3 23 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.4M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $503.0M |
| Total Assets | $4.5B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.4M | — | ||
| Q3 25 | — | $490.9M | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $46.2M | — | ||
| Q2 24 | $31.9M | — | ||
| Q1 24 | $18.8M | — | ||
| Q4 23 | $17.5M | — | ||
| Q3 23 | $19.3M | — |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.7B | — | ||
| Q4 23 | $1.9B | — | ||
| Q3 23 | $1.8B | — |
| Q1 26 | $2.6B | — | ||
| Q3 25 | — | $503.0M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — | ||
| Q4 23 | $1.6B | — | ||
| Q3 23 | $1.7B | — |
| Q1 26 | $4.5B | — | ||
| Q3 25 | — | $577.1M | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.3B | — | ||
| Q4 23 | $4.3B | — | ||
| Q3 23 | $4.3B | — |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.95× | — | ||
| Q1 24 | 0.98× | — | ||
| Q4 23 | 1.14× | — | ||
| Q3 23 | 1.08× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | 1.7% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q3 25 | — | $-84.6M | ||
| Q4 24 | $140.4M | — | ||
| Q3 24 | $44.6M | — | ||
| Q2 24 | $32.0M | — | ||
| Q1 24 | $26.0M | — | ||
| Q4 23 | $40.6M | — | ||
| Q3 23 | $25.7M | — |
| Q1 26 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q1 26 | 1.7% | — | ||
| Q3 25 | — | 0.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q4 24 | 121.08× | — | ||
| Q3 24 | 3.64× | — | ||
| Q2 24 | 20.25× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AKR
| Rental | $98.6M | 96% |
| Other | $4.4M | 4% |
VRDN
Segment breakdown not available.
